Thermo King By Trane Technologies Launches Cold Storage Solutions To Support COVID-19 Vaccine Distribution
Thermo King, by Trane Technologies (NYSE:TT), a global climate innovator, has expanded its portfolio of temporary storage solutions that can meet the unique requirements of global pharmaceutical companies developing COVID-19 vaccines. Thermo King is the global leader in intelligent end-to-end temperature-controlled cold chain solutions.
Pharmaceutical companies in final-stage clinical trials anticipate they will require strict temperature controls to safeguard their products – down to temperatures as low as -70 degrees Celsius. Thermo King’s solutions can enable these companies and their distributors to ensure the efficacy of their products through the entire cold chain – from air transport to marine, rail, trailer, last-mile delivery and at storage points along the way.
According to the World Health Organization, nearly 20 percent of temperature-sensitive health care products are damaged during transport, and 25 percent of vaccines reach their destination in a degraded state due to breaks in the cold chain.
“Considering the urgent, global need for a COVID-19 vaccine, the world can’t afford breaks in the cold chain,” said Dave Regnery, president and chief operating officer of Trane Technologies. “Our new Cold Storage Solutions can maintain temperatures of -70 degrees Celsius for an extended period of time, can be leveraged to help reduce degradation of a vaccination, and most importantly, could prevent vaccine ‘deserts’ or lack of accessibility.”
Thermo King and its worldwide partners can offer temporary storage solutions that maintain a set point down to -70 degrees Celsius, and can ensure end-to-end temperature control, security and traceability through state-of-the-art telematics. Additional storage solutions include refrigerated trailers, containers and portable cubes that can easily be scaled and repositioned to other locations as demand changes.
In addition to launching Cold Storage Solutions, Thermo King has helped customers identify ways to maximize the range of dry ice, which is often used in vaccine transport and storage but has certain limitations. A container using dry ice to keep a product frozen may require re-icing if it sits for an extended length of time or is exposed to extreme ambient weather. Thermo King offers storage solutions that can substantially extend the life of dry ice, or eliminate the need altogether.
“We have been engaging pharmaceutical and transport companies, policymakers, regulators and other industry partners to discuss ways to strengthen the cold chain,” said Regnery. “We know that we can help mitigate risk – we have a long history in cold chain expertise, and are actively working to innovate and address the complexities and potential challenges of the mass distribution of a temperature-sensitive vaccine.”
About Thermo King: Thermo King – by Trane Technologies (NYSE:TT), a global climate innovator – is a worldwide leader in sustainable transport temperature control solutions. Thermo King is the only company that delivers connected, end-to-end temperature-controlled transport and storage solutions across the cold chain. For more information visit www.thermoking.com. Source: Trane Technologies plc, contact: Jennifer Regina, at Jennifer.regina@tranetechnologies.com
NOTE: Countries that need this vaccine are required to prepare a mapping of distribution and procurement of appropriate storage, (edited by ARPI).
